MSGM Q1 2026 Earnings First Profitability Milestone Despite Market Skepticism Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment Tonix Pharmaceuticals Q1 2026 Earnings WiderThanExpected Loss Compounds Investor Concerns Douglas Emmett Inc DEI Q1 2026 Earnings Narrowing Losses as EPS Beats Estimates Burford Capital Q1 2026 Earnings Substantial EPS Miss Reflects Volatility in Litigation Finance CIG Q1 2026 Earnings Earnings Beat Shines Amid Quiet Market Response FRHC Q1 2026 Earnings Strong EPS Performance Reflects Solid Operational Execution PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress LAUR Q1 2026 Earnings EPS Beats Estimates Despite Negative Print Stock Slips Southern Company SOJE Q1 2026 Earnings EPS Surpasses Estimates as Utility Operations Deliver Steady Results QRHC Q1 2026 Earnings EPS Misses Estimates by 27 as Stock Edges Up TaskUs TASK Q1 2026 Earnings EPS Slightly Misses Estimates Amid Modest Revenue Headwinds Omada Health Q1 2026 Earnings Narrower Loss Beat Estimates as Company Focuses on Operational Efficiency Cheche Group Q4 2024 Earnings Narrowed Loss Beats Estimates Despite Stock Decline GOOG Q1 2026 Earnings EPS Misses Estimates as Cloud and AI Costs Weigh EPR Properties Q1 2026 Earnings EPS Beats Estimates by 11 as Experiential Portfolio Shows Resilience GLIBA Q1 2026 Earnings Significant Earnings Miss as EPS Falls Well Below Estimates IHS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Macro Environment MLP Q1 2024 Earnings Net Loss Persists Stock Declines